Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 926-931

  Remacle, A G ^a   Noel A ^a,b   Duggan, C ^b   McDermott, E ^b   O'Higgins, N ^b   Foidart, J M ^a   Duffy, M J ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Breast cancer; Gelatinase; Interstitial collagenase and matrix metalloproteinase; Stromelysin

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE; STROMELYSIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GELATIN ZYMOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0031937615     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.153     Document Type: Article

References (41)

1. Alvarez OA, Carmichael DF and DeClerck YA (1990) Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinase. J Natl Cancer Inst 82: 588-595
2. Apte SS, Olsen BR and Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270: 14313-14318
3. Atkinson SJ, Ward RV, Reynolds JJ and Murphy G (1992) Cell mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. Biochem J 288: 605-611
4. Autio-Harmainen H, Karttunen T, Hurskainen T, Hoyhtya M, Kauppila A and Tryggvason K (1993) Expression of 72 kDa type IV collagenase (gelatinase A) in benign and malignant ovarian tumours. Lab Invest 69: 312-321
5. Aznavooran S, Murphy AN, Stetler-Stevenson WG and Liotta LA (1993) Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383
6. Brown PD, Levy AT, Marguelies I, Liotta LA and Stetler-Stevenson WG (1990) Independent expression and cellular processing of the 72 kDa type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191
7. Brown PD, Bloxridge RE, Anderson E and Howell A (1993) Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11: 183-189
8. Brown PD and Giavazzi R (1995) Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 6: 967-974
9. Chen JM, Aimes RT, Ward GR, Youndlieb GL and Quigley JP (1991) Isolation and characterisation of a 70 kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem 266: 5113-5121
10. Chenard MP, O'Siorain L, Shering S, Rouyer N, Lutz Y, Wolf C, Basset P, Bellocq JP and Duffy MJ (1996) High levels of stromelysin-3 correlate with pool prognosis in patients with breast carcinoma. Int J Cancer 69: 448-451
11. Daidone MG, Silvestrini R, D'Errico A, Di Fronza G, Benini E, Mancini AM, Garbisa S, Liotta LA and Grigioni WF (1991) Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 48: 529-532
12. Davies B, Miles DW, Happerfield LC, Naylor MS, Borrow LG, Rubens RD and Balkwiller FR (1993) Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131
13. DeClerck YA, Yean T, Ratzin BJ, Lu HS and Langley KE (1989) Purification and characterisation of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264: 17445-17453
14. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KC and Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708.
15. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG and Grigioni WF (1991) Augmentation of collagenase IV, laminin receptor and Ki62 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4: 239-246
16. Duffy MJ (1992) The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Methods 10: 145-155
17. Duffy MJ, O'Siorain L, Waldron B and Smith C (1986) Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies. Clin Chem 32: 1972-1974
18. Duffy MJ, Blaser J, Duggan C, McDermott E, O'Higgins N, Fennelly JJ and Tschesche H (1995) Assay of matrix metalloproteinases types 8 and 9 by ELISA in human breast cancer. Int J Cancer 61: 597-600
19. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuet M, Kraust S, Komarek D, Liotta LA, Berman ML and Stetler-Stevenson WG (1992) Domain structure of human 72 kDa gelatinase/type IV collagenase. Characterisation of proteolytic activity and identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding regions. J Biol Chem 267: 15398-15404
20. Greene L, Wang M, Xiao G, Liu YE and Shi YE (1996) Loss of expression of TIMP-4, a novel human tissue inhibitor of metalloproteinase, in human breast cancer progression Proc Am Assoc Cancer Res 37: 91
21. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor induced host response. Am J Pathol 149: 273-282
22. Heussen C and Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerised substrates. Anal Biochem 102: 196-202
23. Hoyhtya M, Hujanen E and Turpeenuiemi-Hajanen T (1990) Modulation of type IV collagenase and invasive behaviour of metastatic melanoma (A 2058) cells in vitro by monoclonal antibodies to type IV collagenase. Int J Cancer 46: 282-286
24. Ito A, Nakajima S, Sasaguri Y, Nagase H and Mori Y (1995) Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1,2 and 3 in fibroblasts. Br J Cancer 71: 1039-1045
25. Kleiner DE and Stetler-Stevenson WG (1993) Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 5: 891-897
26. Leco KJ, Khokha R, Pavloff N, Hawkes SP and Edwards DR (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352-9360
27. Liabakk NB, Talbot I, Smith RA, Wilkinson K and Balkwill F (1996) Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer 56: 190-196
28. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trend Genet 6: 121-125
29. McDougall JR and Matrisian LM (1995) Contributions of tumor and stromal matrix metalloproteinases to tumour progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362
30. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG (1990) Immunohistochemical distribution of collagenase IV in normal, benign and malignant breast tissue. Am J Pathol 136: 585-592
31. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F and Docherty AJP (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269: 6632-6636
32. Noël A, Polette M, Emonard H, Munaut C, Birembaut P and Foidart JM (1994) Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast adenocarcinoma cells. Int J Cancer 56: 331-336
33. Polette M, Clavel C, Cockett M, Giorod de Bentzmann S, Murphy G and Birembaut P (1993) Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Inv Metastasis 13: 31-37
34. Remacle AG, Baramova EN, Weidle UH, Krell HW and Foidart JM (1995) Purification of progelatinases A and B by continuous-elution eletrophoresis. Prot Expr Purif 6: 417-422
35. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-64
36. Sier CJM, Kubben FJGM, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JHJM, Lamers CBHW and Verspaget HW (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74: 413-417
37. Sik Lee K, Young Rha S, Joong Kim S, Hang Kim J, Kyung Roh J, Soo Kim B and Cheol Chung H (1996) Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis 14: 512-519
38. Stearns MA and Wang M (1993) Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53: 878-883
39. Takino T, Sato H, Shinagawa A and Seiki M (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270: 23013-23020
40. Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD and Fridman R (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumour recurrence. Int J Cancer 59: 339-344
41. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI (1989) SV-40 transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264: 17212-17321